Onartuzumab (MetMAb) is a humanized anti-tyrosine kinase c-MET monovalent monoclonal antibody.Onartuzumab has antitumor activity with inhibitory effects on HGF binding, receptor phosphorylation, and signal transduction.
Purity:
97.30%
CAS Number:
[1133766-06-9]
Target:
c-Met/HGFR
T76780
T76780
* VAT and and shipping costs not included. Errors and price changes excepted
